Polaris Market Research today announced findings from its latest report, projecting the global branded generics market to grow from USD 265.9 billion in 2024 to USD 410.86 billion by 2032, registering a CAGR of 5.6% during the forecast period. The market is being shaped by the rising prevalence of chronic diseases, increasing demand for affordable medicines, patent expirations, government initiatives supporting generic drugs, and continued pharmaceutical product launches. The report evaluates the market across drug class, application, distribution channel, and region.

Key Growth Drivers, Major Companies and Segments Covered

Growth Drivers: The growing prevalence of chronic conditions such as diabetes, cancer, and cardiovascular diseases is increasing demand for pharmaceutical treatments. Branded generics provide an alternative to higher-priced innovator medicines after patent protection expires, supporting broader access to treatments while creating opportunities for pharmaceutical manufacturers.

Patent expirations are another important factor because they allow manufacturers to introduce equivalent generic products into the market. Government efforts to promote affordable medicines and reduce healthcare expenditure are also supporting adoption. At the same time, pharmaceutical companies continue to invest in product launches and value-added or complex generic formulations.

Major Companies Covered:

• Teva Pharmaceutical
• Lupin
• Sanofi
• Sun Pharmaceutical Industries
• Dr. Reddy's Laboratories
• Endo International
• GlaxoSmithKline
• Pfizer
• Apotex
• Viatris

Segments Covered: By Drug Class, the market includes Alkylating Agents, Antimetabolites, Hormones, Anti-Hypertensive, Lipid Lowering Drugs, Anti-Depressants, Anti-Psychotics, Anti-Epileptics, and Others. By Application, it covers Oncology, Cardiovascular Diseases, Neurological Diseases, Gastrointestinal Diseases, Dermatological Diseases, Acute and Chronic Pain, and Others. By Distribution Channel, the report covers Topical, Oral, Parenteral, and Others, alongside regional analysis.

Browse More Information:

https://www.polarismarketresearch.com/industry-analysis/branded-generics-market 

Market Dynamics and Segment Highlights

The anti-hypertensive segment accounted for the largest market share in 2022. Increasing demand for treatments associated with cardiovascular and metabolic conditions is supporting this segment. The hormones segment is also expected to register significant growth as metabolic disorders and hormone-related conditions continue to create demand for pharmaceutical therapies.

By application, gastrointestinal diseases represented a significant revenue share in 2022. Increasing prevalence of gastrointestinal conditions and continued demand for therapies such as proton pump inhibitors are contributing to the segment. Oncology also represents an important application area as cancer incidence continues to drive demand for pharmaceutical treatments.

Retail pharmacies held the largest distribution share in 2022. Their extensive consumer reach and purchasing scale have helped support the distribution of branded generic medicines, while hospital pharmacies continue to represent an important channel for medicines used in critical and acute care.

Recent Developments in the Branded Generics Market

In October 2025, the U.S. FDA approved an expanded indication for UZEDY, an extended-release risperidone injectable suspension, allowing its use for schizophrenia in children and adolescents aged 13 to 17 in addition to adults.

In August 2025, Teva received U.S. FDA approval and launched the first generic version of Saxenda, or liraglutide injection, for weight management in adults and pediatric patients.

In March 2023, Viatris, Aurobindo Pharma, and Cipla received sublicenses from the Medicines Patent Pool to produce affordable branded generic versions of Apretude for HIV prevention.

Regional Snapshot: North America Leads, Asia Pacific Expands

North America dominated the branded generics market in 2022 and is expected to maintain its leading position during the forecast period. Strong pharmaceutical infrastructure, established healthcare systems, and significant penetration of generic medicines are supporting the regional market.

Asia Pacific is expected to register the fastest growth. Countries such as India have developed significant pharmaceutical manufacturing capabilities and serve as major suppliers of affordable medicines. Increasing healthcare needs, manufacturing investment, and efforts to address shortages of essential medicines are expected to support regional expansion.

The COVID-19 pandemic disrupted pharmaceutical manufacturing, transportation, distribution, and regulatory operations. Lockdowns and travel restrictions affected supply chains, while delays in approvals and health technology assessments affected the launch of certain medicines. The pharmaceutical sector has subsequently continued to adapt to changing supply-chain and healthcare requirements.

Why It Matters for Pharmaceutical Stakeholders

For pharmaceutical manufacturers, healthcare providers, distributors, investors, and policymakers, the branded generics market provides insight into changing demand for affordable medicines, patent-expiration opportunities, drug-class trends, distribution patterns, and regional pharmaceutical development. The report also examines competitive conditions, industry dynamics, and future growth opportunities through 2032.

Conclusion

The global branded generics market is expected to continue expanding as healthcare systems seek affordable treatment options and pharmaceutical companies respond to patent expirations and growing chronic-disease prevalence. With revenue projected to reach USD 410.86 billion by 2032 at a CAGR of 5.6%, drug launches, generic manufacturing capabilities, retail pharmacy distribution, and growing pharmaceutical activity in Asia Pacific are expected to remain important factors shaping the market.

More Trending Latest Reports By Polaris Market Research:

Well Intervention Market

Hospital Outsourcing Market

Eyelash Serum Market

Welding Materials Market

Fiber Laser Market

Mortuary Bags Market

Mortuary Bags Market

Eyelash Serum Market

Medical Stampings Market